Oppenheimer Downgrades IBM After 25% Post-Earnings Plunge

Oppenheimer Research downgraded IBM (IBM) to "underperform" and withdrew its price target entirely, following the stock's sharp 25% single-day drop after the company reported Q4 2025 earnings. The downgrade serves as a warning to investors about possible continued pressure on the stock.

Rating Change

Previously, Oppenheimer rated IBM as "outperform" with a specific price target. After the plunge, the firm downgraded the stock to "underperform" and withdrew the price target, indicating a lack of clarity on the stock's future.

Analyst Rationale

Oppenheimer analysts believe the steep decline reflects fundamental concerns about IBM's results and forward guidance. The warning focuses on the potential for continued negative volatility, especially amid an uncertain economic environment and slowing corporate IT spending.

Context

The downgrade comes after IBM recorded its worst single-day performance in years, losing a quarter of its market value in one session. Other analysts have yet to update their ratings, but Oppenheimer's warning may prompt some to reassess.

What to Conclude

Oppenheimer's downgrade is a cautionary signal for investors, but it does not necessarily mean the stock will continue to fall. Future performance hinges on IBM's ability to improve results and provide positive guidance. Investors are advised to monitor upcoming quarterly reports and evaluate fundamentals independently.